首页> 美国卫生研究院文献>AAPS PharmSci >Neuropeptide-processing enzymes: Applications for drug discovery
【2h】

Neuropeptide-processing enzymes: Applications for drug discovery

机译:神经肽加工酶:药物发现的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neuropeptides serve many important roles in communication between cells and are an attractive target for drug discovery. Neuropeptides are produced from precursor proteins by selective cleavages at specific sites, and are then broken down by further cleavages. In general, the biosynthetic cleavages occur within the cell and the degradative cleavages occur postsecretion, although there are exceptions where intracellular processing leads to inactivation, or extracellular processing leads to activation of a particular neuropeptide. A relatively small number of peptidases are responsible for processing the majority of neuropeptides, both inside and outside of the cell. Thus, inhibition of any one enzyme will lead to a broad effect on several different neuropeptides and this makes it unlikely that such inhibitors would be useful therapeutics. However, studies with mutant animals that lack functional peptide-processing enzymes have facilitated the discovery of novel neuropeptides, many of which may be appropriate targets for therapeutics.
机译:神经肽在细胞之间的通讯中起着许多重要的作用,并且是药物发现的有吸引力的靶标。神经肽通过在特定位点的选择性切割从前体蛋白产生,然后通过进一步切割而分解。通常,虽然细胞内加工导致失活,或细胞外加工导致特定神经肽活化,但有例外,细胞内发生生物合成裂解,分泌后发生降解裂解。相对少量的肽酶负责处理细胞内外的大多数神经肽。因此,任何一种酶的抑制将导致对几种不同神经肽的广泛作用,这使得这种抑制剂不太可能成为有用的治疗剂。然而,对缺乏功能性肽加工酶的突变动物的研究促进了新型神经肽的发现,其中许多神经肽可能是治疗的合适靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号